Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
India will now tighten its grip on Bangladesh, a big report has come regarding the attack on Hindus.
India's attitude will be more strict against the interim government and head of the government Pr
The prime accused in the recent grenade attack on a temple in Amritsar was killed in a police enc
India's 'Operation Sindoor' is going on, and once again the Pakistani team has lost badly on the
Lok Sabha elections are going on across the country. All political parties are campaigning vigoro
Bengal Chief Minister Mamata Banerjee on Tuesday launched a scathing attack on various national c
104 Indians who had entered the US illegally have returned to their homeland. On Wednesday, a US
These players will not go to Dubai with Team India for the Asia Cup 2025 BCCI took a surprising step
All the teams have geared up for the Asia Cup starting next month in the United Arab Emirates. Te
Rescue operations continued for the third day to evacuate the pilgrims stranded in Kedarnath. A d
As told in the review of the first episode of Netflix's new show 'The Great I
Operation Sindoor India has taken its revenge exactly 15 days after the Pahalgam Terror Attack. L
